CAS 2229047-91-8

Glofitamab

CAS : 2229047-91-8

Glofitamab (RO7082859), a bivalent antibody, targets CD20 on B-cells to aid T cell attack in relapsed/refractory lymphomas.

Degré de pureté : SDS-PAGE:98.2%;SEC-HPLC:98.0%

Couleur et forme : Liquid

Masse moléculaire : 170.37 kDa

Ref: TM-T76685

Glofitamab

CAS : 2229047-91-8

Anti-Human CD3xCD20 Bispecific Antibody

Ref: 3D-CLA1659